이경민 교수의 진료시간표

이경민 교수의 상세정보

• 2007 .03  ~  2013 .02  :  고려대학교 의과대학 의학사
• 2016 .03  ~  2018 .02  :  울산대학교 의과대학 의학석사

• 2018 .03  ~  2019 .08  :  서울아산병원 종양내과 임상강사
• 2019 .09  ~  2020 .02  :  고대구로병원 혈액종양내과 임상강사
• 2020 .03  ~   :  고대구로병원 혈액종양내과 임상조교수대우

• 2019 .05  :  한국암학술재단 학술상

• [SCI] (The clinical outcomes of rituximab biosimilar CT-P10 (Truxima((R))) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world experience.)
• [SCI] (The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions)
• [SCI] (Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.)
• [SCI] (Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center.)
• [SCI] (Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis)
• [SCI] (Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.)

최종수정일 : 2021.02.22